Correlation of expression of ABH blood group carbohydrate antigens with metastatic potential in human lung carcinomas

Cancer

Volumn 72, Issue 1, 1993, Pages 75-81

  Matsumoto, Hidehiko ^a   Muramatsu, Hisako ^a   Shimotakahara, Tetsurou ^a   Yanagi, Masakazu ^a   Nishijima, Hiroo ^a   Mitani, Nobuyuki ^a   Baba, Kuniaki ^a   Muramatsu, Takashi ^a   Shimazu, Hisaaki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

blood group antigen; human lung carcinoma; metastatic potential; prognosis

Indexed keywords

BLOOD GROUP ABH ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP ABO SYSTEM; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGE; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; SUPPORT, NON-U.S. GOV'T;

EID: 0027281324     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z     Document Type: Article

References (29)

1. x in the sera of cancer patients detected by a cell‐binding inhibition assay
2. Colorectal carcinoma antigens detected by hybridoma antibodies
3. Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma
4. Carbohydrate determinants associated with carcinoembryonic antigen (CEA)
5. Isolation and properties of a human pancreatic adenocarcinoma‐associated antigen, DU‐PAN‐2
6. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives
7. Stage‐specific embryonic antigen involves 1–3 fucosylated type 2 blood group chains
8. b substances
9. Blood group antigens as markers for normal differentiation and malignant change in human tissues
10. Distribution of blood group antigens A, B, H, and I(Ma) in mucus producing adenocarcinoma of human lung
11. Use of monoclonal antibodies for the localization of tissue isoantigens A and B in transitional cell carcinoma of the upper urinary tract
12. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder
13. Differences in clinical significance of blood group antigens A, B, and H in carcinoma tissue in the uterine cervix
14. Cancer‐associated alterations of blood group antigen expression in the human pancreas
15. Distribution of blood group antigens and CA19‐9 in gastric cancers and non‐neoplastic gastric mucosa
16. The distribution of blood group substance H and CEA in colorectal carcinoma
17. Immunohistochemistry of the blood group A, B, H isoantigens and Oxford Ca antigen as prognostic markers for stage IB squamous cell carcinoma of the cervix
18. Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma
19. Relation of ABH blood group antigen expression to prognosis in lung carcinoma
20. Expression of blood‐group antigen A: a favorable prognostic factor in non‐small‐cell lung cancer
21. Versatility of biotin‐labeled lectins and avidin‐biotin‐peroxidase complex for localization of carbohydrate in tissue sections
22. Cytochemical demonstration of peroxidase activity with 3‐amino‐9‐ethylcarbazole
23. Carbohydrate profiles revealed by a lectin and a monoclonal antibody correlate with metastatic potential and prognosis of human lung carcinomas
24. An anti‐carbohydrate monoclonal antibody inhibits cell‐substratum adhesion of F9 embryonal carcinoma cells
25. The prognostic value of Lauren's histopathological classification system and ABO blood groups in patients with stomach carcinoma
26. Isoantigens A, B and H in primary liver malignancies
27. ABH blood group isoantigen expression in breast carcinomas: an immunohistochemical evaluation using monoclonal antibodies
28. Carbohydrate ligands of the LEC cell adhesion molecules